Chatham Capital Group Inc. Sells 8,530 Shares of UnitedHealth Group Incorporated $UNH

Chatham Capital Group Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 75.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,742 shares of the healthcare conglomerate’s stock after selling 8,530 shares during the quarter. Chatham Capital Group Inc.’s holdings in UnitedHealth Group were worth $947,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the stock. North Capital Inc. lifted its stake in UnitedHealth Group by 16.2% in the 3rd quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock worth $67,000 after purchasing an additional 27 shares in the last quarter. Sunflower Bank N.A. lifted its holdings in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate’s stock worth $662,000 after acquiring an additional 28 shares during the last quarter. Abound Wealth Management increased its stake in UnitedHealth Group by 13.5% in the third quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate’s stock valued at $84,000 after acquiring an additional 29 shares during the last quarter. GK Wealth Management LLC lifted its stake in UnitedHealth Group by 7.2% during the first quarter. GK Wealth Management LLC now owns 506 shares of the healthcare conglomerate’s stock worth $265,000 after purchasing an additional 34 shares during the last quarter. Finally, Western Pacific Wealth Management LP increased its position in shares of UnitedHealth Group by 12.0% during the 2nd quarter. Western Pacific Wealth Management LP now owns 336 shares of the healthcare conglomerate’s stock valued at $105,000 after purchasing an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Jefferies Financial Group lifted their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Sanford C. Bernstein boosted their target price on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Finally, Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Stock Down 0.1%

Shares of NYSE UNH opened at $324.75 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a fifty day simple moving average of $335.45 and a two-hundred day simple moving average of $318.68. The firm has a market capitalization of $294.17 billion, a PE ratio of 16.95, a price-to-earnings-growth ratio of 2.12 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business posted $7.15 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.